BioAge Labs Cash Flow Statement 2023-2025 | BIOA

Fifteen years of historical annual cash flow statements for BioAge Labs (BIOA).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20242023
$-71.11$-63.85
$0.17$0.16
$8.24$19.62
$8.41$19.78
$0$0
$0$0
$0.01$-0.39
$6.54$3.38
$11.18$6.71
$-51.52$-37.36
$-0.37$-0.17
$0$0
$0$0
$0$0
$0$-0.10
$0$-0.10
$0$0
$-0.37$-0.27
$-6.00$35.00
$0$0
$-6.00$35.00
$222$0.00
$392$0.00
$0$0
$-5.05$-0.06
$381$34.94
$329$-2.69
$6.98$3.02
$0$0